Pfizer | PFE - Рыночная капитализация





Рыночная капитализация Изменить Дата
AbbVie USD 435.86B 8.73B 2026-08
Abbott USD 158.05B 20.36B 2026-06
ALKERMES USD 7.93B 806M 2026-08
Amgen USD 209.65B 14.21B 2026-08
AstraZeneca USD 178.16B 111.83B 2026-08
Bayer EUR 48.39B 834.21M 2026-08
Biogen USD 31.9B 5B 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 11.07B 619M 2026-03
Eli Lilly USD 1.11T 18.32B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Glaxosmithkline GBP 109.29B 9.36B 2026-03
J&J USD 611.36B 32.21B 2026-06
Merck USD 324.18B 6.81B 2026-08
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Pacira USD 1.28B 286M 2026-08
Perrigo USD 1.45B 135M 2026-08
Pfizer USD 153.17B 14.73B 2026-08
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.7B 463M 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08
Zoetis USD 35.38B 5.25B 2026-08